Clinical Trials List
Protocol Number664
2011-04-01 - 2012-04-30
Phase III
Terminated2
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 張聰麒 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 陳冠仁 Division of Ophthalmology
- Wei-Chi WU Division of Ophthalmology
- Chi-Chun Lai Division of Ophthalmology
- 王南凱 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
300 participants
